I'll tell you why. A2M has CFDA approval and BAL has no SAMR approval. Looks like it will NEVER happen. Can't wait for the forward looking guidance on this missed opportunity.
$23 happened because unsuspecting speculators expected CFDA approval.
BAL Price at posting:
$8.13 Sentiment: Sell Disclosure: Held